Carregant...
Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
BACKGROUND: Throughout 2007 and January 2008, several glitazones health warnings were published on rosiglitazone myocardial infarction risk. The impact of such warnings on glitazones prevalence of utilization has been extensively studied in the United States but only in one European country (England...
Guardat en:
| Publicat a: | SAGE Open Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4989582/ https://ncbi.nlm.nih.gov/pubmed/27579167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312116653054 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|